Global Thalassemia Market Size, Status and Forecast 2020-2026

May 2020 | 97 pages | ID: GF9CBE30775DEN
QYResearch

Abstracts

This report focuses on the global Thalassemia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thalassemia development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Bluebird bio, Inc.
• Acceleron Pharma, Inc.
• Celgene Corporation
• GlaxoSmithKline plc
• Incyte Corporation
• Gamida Cell
• Kiadis Pharma
• La Jolla Pharmaceutical Company
• IONIS Pharmaceuticals

Market segment by Type, the product can be split into

• Iron Chelating Drugs
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Research Institute
• Laboratories

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Thalassemia status, future forecast, growth opportunity, key market and key players.
• To present the Thalassemia development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Thalassemia are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Thalassemia Revenue
1.4 Market Analysis by Type
  1.4.1 Global Thalassemia Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Iron Chelating Drugs
  1.4.3 Others
1.5 Market by Application
  1.5.1 Global Thalassemia Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Research Institute
  1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Thalassemia Market Perspective (2015-2026)
2.2 Thalassemia Growth Trends by Regions
  2.2.1 Thalassemia Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Thalassemia Historic Market Share by Regions (2015-2020)
  2.2.3 Thalassemia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Thalassemia Market Growth Strategy
  2.3.6 Primary Interviews with Key Thalassemia Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Thalassemia Players by Market Size
  3.1.1 Global Top Thalassemia Players by Revenue (2015-2020)
  3.1.2 Global Thalassemia Revenue Market Share by Players (2015-2020)
  3.1.3 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Thalassemia Market Concentration Ratio
  3.2.1 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Thalassemia Revenue in 2019
3.3 Thalassemia Key Players Head office and Area Served
3.4 Key Players Thalassemia Product Solution and Service
3.5 Date of Enter into Thalassemia Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Thalassemia Historic Market Size by Type (2015-2020)
4.2 Global Thalassemia Forecasted Market Size by Type (2021-2026)

5 THALASSEMIA BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Thalassemia Market Size by Application (2015-2020)
5.2 Global Thalassemia Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Thalassemia Market Size (2015-2020)
6.2 Thalassemia Key Players in North America (2019-2020)
6.3 North America Thalassemia Market Size by Type (2015-2020)
6.4 North America Thalassemia Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Thalassemia Market Size (2015-2020)
7.2 Thalassemia Key Players in Europe (2019-2020)
7.3 Europe Thalassemia Market Size by Type (2015-2020)
7.4 Europe Thalassemia Market Size by Application (2015-2020)

8 CHINA

8.1 China Thalassemia Market Size (2015-2020)
8.2 Thalassemia Key Players in China (2019-2020)
8.3 China Thalassemia Market Size by Type (2015-2020)
8.4 China Thalassemia Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Thalassemia Market Size (2015-2020)
9.2 Thalassemia Key Players in Japan (2019-2020)
9.3 Japan Thalassemia Market Size by Type (2015-2020)
9.4 Japan Thalassemia Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Thalassemia Market Size (2015-2020)
10.2 Thalassemia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Thalassemia Market Size by Type (2015-2020)
10.4 Southeast Asia Thalassemia Market Size by Application (2015-2020)

11 INDIA

11.1 India Thalassemia Market Size (2015-2020)
11.2 Thalassemia Key Players in India (2019-2020)
11.3 India Thalassemia Market Size by Type (2015-2020)
11.4 India Thalassemia Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Thalassemia Market Size (2015-2020)
12.2 Thalassemia Key Players in Central & South America (2019-2020)
12.3 Central & South America Thalassemia Market Size by Type (2015-2020)
12.4 Central & South America Thalassemia Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bluebird bio, Inc.
  13.1.1 Bluebird bio, Inc. Company Details
  13.1.2 Bluebird bio, Inc. Business Overview and Its Total Revenue
  13.1.3 Bluebird bio, Inc. Thalassemia Introduction
  13.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2015-2020))
  13.1.5 Bluebird bio, Inc. Recent Development
13.2 Acceleron Pharma, Inc.
  13.2.1 Acceleron Pharma, Inc. Company Details
  13.2.2 Acceleron Pharma, Inc. Business Overview and Its Total Revenue
  13.2.3 Acceleron Pharma, Inc. Thalassemia Introduction
  13.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2015-2020)
  13.2.5 Acceleron Pharma, Inc. Recent Development
13.3 Celgene Corporation
  13.3.1 Celgene Corporation Company Details
  13.3.2 Celgene Corporation Business Overview and Its Total Revenue
  13.3.3 Celgene Corporation Thalassemia Introduction
  13.3.4 Celgene Corporation Revenue in Thalassemia Business (2015-2020)
  13.3.5 Celgene Corporation Recent Development
13.4 GlaxoSmithKline plc
  13.4.1 GlaxoSmithKline plc Company Details
  13.4.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  13.4.3 GlaxoSmithKline plc Thalassemia Introduction
  13.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2015-2020)
  13.4.5 GlaxoSmithKline plc Recent Development
13.5 Incyte Corporation
  13.5.1 Incyte Corporation Company Details
  13.5.2 Incyte Corporation Business Overview and Its Total Revenue
  13.5.3 Incyte Corporation Thalassemia Introduction
  13.5.4 Incyte Corporation Revenue in Thalassemia Business (2015-2020)
  13.5.5 Incyte Corporation Recent Development
13.6 Gamida Cell
  13.6.1 Gamida Cell Company Details
  13.6.2 Gamida Cell Business Overview and Its Total Revenue
  13.6.3 Gamida Cell Thalassemia Introduction
  13.6.4 Gamida Cell Revenue in Thalassemia Business (2015-2020)
  13.6.5 Gamida Cell Recent Development
13.7 Kiadis Pharma
  13.7.1 Kiadis Pharma Company Details
  13.7.2 Kiadis Pharma Business Overview and Its Total Revenue
  13.7.3 Kiadis Pharma Thalassemia Introduction
  13.7.4 Kiadis Pharma Revenue in Thalassemia Business (2015-2020)
  13.7.5 Kiadis Pharma Recent Development
13.8 La Jolla Pharmaceutical Company
  13.8.1 La Jolla Pharmaceutical Company Company Details
  13.8.2 La Jolla Pharmaceutical Company Business Overview and Its Total Revenue
  13.8.3 La Jolla Pharmaceutical Company Thalassemia Introduction
  13.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2015-2020)
  13.8.5 La Jolla Pharmaceutical Company Recent Development
13.9 IONIS Pharmaceuticals
  13.9.1 IONIS Pharmaceuticals Company Details
  13.9.2 IONIS Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 IONIS Pharmaceuticals Thalassemia Introduction
  13.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2015-2020)
  13.9.5 IONIS Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Thalassemia Key Market Segments
Table 2. Key Players Covered: Ranking by Thalassemia Revenue
Table 3. Ranking of Global Top Thalassemia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Thalassemia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Iron Chelating Drugs
Table 6. Key Players of Others
Table 7. Global Thalassemia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Thalassemia Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Thalassemia Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Thalassemia Market Share by Regions (2015-2020)
Table 11. Global Thalassemia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Thalassemia Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Thalassemia Market Growth Strategy
Table 17. Main Points Interviewed from Key Thalassemia Players
Table 18. Global Thalassemia Revenue by Players (2015-2020) (Million US$)
Table 19. Global Thalassemia Market Share by Players (2015-2020)
Table 20. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thalassemia as of 2019)
Table 21. Global Thalassemia by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Thalassemia Product Solution and Service
Table 24. Date of Enter into Thalassemia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 27. Global Thalassemia Market Size Share by Type (2015-2020)
Table 28. Global Thalassemia Revenue Market Share by Type (2021-2026)
Table 29. Global Thalassemia Market Size Share by Application (2015-2020)
Table 30. Global Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 31. Global Thalassemia Market Size Share by Application (2021-2026)
Table 32. North America Key Players Thalassemia Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Thalassemia Market Share (2019-2020)
Table 34. North America Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 35. North America Thalassemia Market Share by Type (2015-2020)
Table 36. North America Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 37. North America Thalassemia Market Share by Application (2015-2020)
Table 38. Europe Key Players Thalassemia Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Thalassemia Market Share (2019-2020)
Table 40. Europe Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Thalassemia Market Share by Type (2015-2020)
Table 42. Europe Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Thalassemia Market Share by Application (2015-2020)
Table 44. China Key Players Thalassemia Revenue (2019-2020) (Million US$)
Table 45. China Key Players Thalassemia Market Share (2019-2020)
Table 46. China Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 47. China Thalassemia Market Share by Type (2015-2020)
Table 48. China Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 49. China Thalassemia Market Share by Application (2015-2020)
Table 50. Japan Key Players Thalassemia Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Thalassemia Market Share (2019-2020)
Table 52. Japan Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Thalassemia Market Share by Type (2015-2020)
Table 54. Japan Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Thalassemia Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Thalassemia Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Thalassemia Market Share (2019-2020)
Table 58. Southeast Asia Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Thalassemia Market Share by Type (2015-2020)
Table 60. Southeast Asia Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Thalassemia Market Share by Application (2015-2020)
Table 62. India Key Players Thalassemia Revenue (2019-2020) (Million US$)
Table 63. India Key Players Thalassemia Market Share (2019-2020)
Table 64. India Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 65. India Thalassemia Market Share by Type (2015-2020)
Table 66. India Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 67. India Thalassemia Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Thalassemia Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Thalassemia Market Share (2019-2020)
Table 70. Central & South America Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Thalassemia Market Share by Type (2015-2020)
Table 72. Central & South America Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Thalassemia Market Share by Application (2015-2020)
Table 74. Bluebird bio, Inc. Company Details
Table 75. Bluebird bio, Inc. Business Overview
Table 76. Bluebird bio, Inc. Product
Table 77. Bluebird bio, Inc. Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 78. Bluebird bio, Inc. Recent Development
Table 79. Acceleron Pharma, Inc. Company Details
Table 80. Acceleron Pharma, Inc. Business Overview
Table 81. Acceleron Pharma, Inc. Product
Table 82. Acceleron Pharma, Inc. Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 83. Acceleron Pharma, Inc. Recent Development
Table 84. Celgene Corporation Company Details
Table 85. Celgene Corporation Business Overview
Table 86. Celgene Corporation Product
Table 87. Celgene Corporation Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 88. Celgene Corporation Recent Development
Table 89. GlaxoSmithKline plc Company Details
Table 90. GlaxoSmithKline plc Business Overview
Table 91. GlaxoSmithKline plc Product
Table 92. GlaxoSmithKline plc Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline plc Recent Development
Table 94. Incyte Corporation Company Details
Table 95. Incyte Corporation Business Overview
Table 96. Incyte Corporation Product
Table 97. Incyte Corporation Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 98. Incyte Corporation Recent Development
Table 99. Gamida Cell Company Details
Table 100. Gamida Cell Business Overview
Table 101. Gamida Cell Product
Table 102. Gamida Cell Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 103. Gamida Cell Recent Development
Table 104. Kiadis Pharma Company Details
Table 105. Kiadis Pharma Business Overview
Table 106. Kiadis Pharma Product
Table 107. Kiadis Pharma Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 108. Kiadis Pharma Recent Development
Table 109. La Jolla Pharmaceutical Company Business Overview
Table 110. La Jolla Pharmaceutical Company Product
Table 111. La Jolla Pharmaceutical Company Company Details
Table 112. La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 113. La Jolla Pharmaceutical Company Recent Development
Table 114. IONIS Pharmaceuticals Company Details
Table 115. IONIS Pharmaceuticals Business Overview
Table 116. IONIS Pharmaceuticals Product
Table 117. IONIS Pharmaceuticals Revenue in Thalassemia Business (2015-2020) (Million US$)
Table 118. IONIS Pharmaceuticals Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Thalassemia Market Share by Type: 2020 VS 2026
Figure 2. Iron Chelating Drugs Features
Figure 3. Others Features
Figure 4. Global Thalassemia Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institute Case Studies
Figure 8. Laboratories Case Studies
Figure 9. Thalassemia Report Years Considered
Figure 10. Global Thalassemia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Thalassemia Market Share by Regions: 2020 VS 2026
Figure 12. Global Thalassemia Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Thalassemia Market Share by Players in 2019
Figure 15. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thalassemia as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Thalassemia Revenue in 2019
Figure 17. North America Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bluebird bio, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Bluebird bio, Inc. Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 26. Acceleron Pharma, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Acceleron Pharma, Inc. Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 28. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Celgene Corporation Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 30. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline plc Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 32. Incyte Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Incyte Corporation Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 34. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Gamida Cell Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 36. Kiadis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Kiadis Pharma Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 38. La Jolla Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. La Jolla Pharmaceutical Company Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 40. IONIS Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. IONIS Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed